BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35174735)

  • 1. Developing Peri-Operative Rehabilitation in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 6]: An Unexplored Opportunity?
    Boerger TF; Hyngstrom AS; Furlan JC; Kalsi-Ryan S; Curt A; Kwon BK; Kurpad SN; Fehlings MG; Harrop JS; Aarabi B; Rahimi-Movaghar V; Guest JD; Wilson JR; Davies BM; Kotter MRN; Koljonen PA
    Global Spine J; 2022 Feb; 12(1_suppl):97S-108S. PubMed ID: 35174735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic repetitive Transcranial Magnetic stimulation (rTMS) for neurological dysfunction in Degenerative cervical Myelopathy: An unexplored opportunity? Findings from a systematic review.
    Gharooni AA; Khan M; Yang X; Anwar F; Davies B; Kotter M
    J Clin Neurosci; 2021 Aug; 90():76-81. PubMed ID: 34275584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of lived experience-centered word clouds to support research uncertainty gathering in degenerative cervical myelopathy: results from an engagement process and protocol for their evaluation, via a nested randomized controlled trial.
    Davies BM; Mowforth OD; Khan DZ; Yang X; Stacpoole SRL; Hazenbiller O; Gronlund T; Tetreault L; Kalsi-Ryan S; Starkey ML; Sadler I; Sarewitz E; Houlton D; Carter J; Howard E; Rahimi-Movaghar V; Guest JD; Aarabi B; Kwon BK; Kurpad SN; Harrop J; Wilson JR; Grossman R; Smith EK; McNair AGK; Fehlings MG; Kotter MRN
    Trials; 2021 Jun; 22(1):415. PubMed ID: 34172080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing Novel Therapies for Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 7]: Opportunities From Restorative Neurobiology.
    Gharooni AA; Kwon BK; Fehlings MG; Boerger TF; Rodrigues-Pinto R; Koljonen PA; Kurpad SN; Harrop JS; Aarabi B; Rahimi-Movaghar V; Wilson JR; Davies BM; Kotter MRN; Guest JD
    Global Spine J; 2022 Feb; 12(1_suppl):109S-121S. PubMed ID: 35174725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing Diagnostic Criteria for Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 3].
    Hilton B; Gardner EL; Jiang Z; Tetreault L; Wilson JRF; Zipser CM; Riew KD; Guest JD; Harrop JS; Fehlings MG; Rodrigues-Pinto R; Rahimi-Movaghar V; Aarabi B; Koljonen PA; Kotter MRN; Davies BM; Kwon BK
    Global Spine J; 2022 Feb; 12(1_suppl):55S-63S. PubMed ID: 35174729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Assessment of Disease Severity and Strategies for Monitoring Progression in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 4].
    Tetreault L; Garwood P; Gharooni AA; Touzet AY; Nanna-Lohkamp L; Martin A; Wilson J; Harrop JS; Guest J; Kwon BK; Milligan J; Arizala AM; Riew KD; Fehlings MG; Kotter MRN; Kalsi-Ryan S; Davies BM
    Global Spine J; 2022 Feb; 12(1_suppl):64S-77S. PubMed ID: 34971524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the Application of Surgery for Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 10].
    Rodrigues-Pinto R; Montenegro TS; Davies BM; Kato S; Kawaguchi Y; Ito M; Zileli M; Kwon BK; Fehlings MG; Koljonen PA; Kurpad SN; Guest JD; Aarabi B; Rahimi-Movaghar V; Wilson JR; Kotter MRN; Harrop JS
    Global Spine J; 2022 Feb; 12(1_suppl):147S-158S. PubMed ID: 35174733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Awareness Could Transform Outcomes in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 1].
    Davies BM; Mowforth O; Wood H; Karimi Z; Sadler I; Tetreault L; Milligan J; Wilson JRF; Kalsi-Ryan S; Furlan JC; Kawaguchi Y; Ito M; Zipser CM; Boerger TF; Vaccaro AR; Murphy RKJ; Hutton M; Rodrigues-Pinto R; Koljonen PA; Harrop JS; Aarabi B; Rahimi-Movaghar V; Kurpad SN; Guest JD; Wilson JR; Kwon BK; Kotter MRN; Fehlings MG
    Global Spine J; 2022 Feb; 12(1_suppl):28S-38S. PubMed ID: 35174734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system.
    Vidal PM; Ulndreaj A; Badner A; Hong J; Fehlings MG
    J Neuroinflammation; 2018 Aug; 15(1):222. PubMed ID: 30081922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gathering Global Perspectives to Establish the Research Priorities and Minimum Data Sets for Degenerative Cervical Myelopathy: Sampling Strategy of the First Round Consensus Surveys of AO Spine RECODE-DCM.
    Mowforth OD; Khan DZ; Wong MY; Pickering GAE; Dean L; Magee J; Mullarkey L; Hirayama Y; Rihova M; Butler M; Stewart M; Goulson B; Ahmed S; Fricke K; Popa-Nimigean V; Millar Z; Venkatesh A; Willison A; Senthil K; Hazenbiller O; Sarewitz E; Sadler I; Gronlund T; Tetreault L; Harrop JS; Aarabi B; Rahimi-Movaghar V; Kurpad SN; Guest JD; Wilson JR; Kwon BK; Fehlings MG; McNair AGK; Davies BM; Kotter MRN;
    Global Spine J; 2022 Feb; 12(1_suppl):8S-18S. PubMed ID: 34879754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Framework for Investigating the Biological Basis of Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 5]: Mechanical Stress, Vulnerability and Time.
    Davies BM; Mowforth O; Gharooni AA; Tetreault L; Nouri A; Dhillon RS; Bednarik J; Martin AR; Young A; Takahashi H; Boerger TF; Newcombe VF; Zipser CM; Freund P; Koljonen PA; Rodrigues-Pinto R; Rahimi-Movaghar V; Wilson JR; Kurpad SN; Fehlings MG; Kwon BK; Harrop JS; Guest JD; Curt A; Kotter MRN
    Global Spine J; 2022 Feb; 12(1_suppl):78S-96S. PubMed ID: 35174728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degenerative Cervical Myelopathy: Development and Natural History [AO Spine RECODE-DCM Research Priority Number 2].
    Nouri A; Tessitore E; Molliqaj G; Meling T; Schaller K; Nakashima H; Yukawa Y; Bednarik J; Martin AR; Vajkoczy P; Cheng JS; Kwon BK; Kurpad SN; Fehlings MG; Harrop JS; Aarabi B; Rahimi-Movaghar V; Guest JD; Davies BM; Kotter MRN; Wilson JR
    Global Spine J; 2022 Feb; 12(1_suppl):39S-54S. PubMed ID: 35174726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Degenerative Cervical Myelopathy From The Perspective of Persons Living With the Condition: Findings of a Semistructured Interview Process With Partnered Internet Survey.
    Davies BM; Munro C; Khan DZ; Fitzpatrick SM; Hilton B; Mowforth OD; McNair AGK; Sadler I; Kotter MRN
    Global Spine J; 2022 Apr; 12(3):432-440. PubMed ID: 33203262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing awareness of degenerative cervical myelopathy: a preventative cause of non-traumatic spinal cord injury.
    Zipser CM; Margetis K; Pedro KM; Curt A; Fehlings M; Sadler I; Tetreault L; Davies BM; ;
    Spinal Cord; 2021 Nov; 59(11):1216-1218. PubMed ID: 34628477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changes in systemic monocytes in humans undergoing surgical decompression for degenerative cervical myelopathy may influence clinical neurological recovery.
    Vidal PM; Ulndreaj A; Tetreault L; Hong J; Fehlings MG
    J Neuroimmunol; 2019 Nov; 336():577024. PubMed ID: 31450156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevailing Outcome Themes Reported by People With Degenerative Cervical Myelopathy: Focus Group Study.
    Khan DZ; Fitzpatrick SM; Hilton B; McNair AG; Sarewitz E; Davies BM; Kotter MR;
    JMIR Form Res; 2021 Feb; 5(2):e18732. PubMed ID: 33533719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing the Socio-Economic Impact of Degenerative Cervical Myelopathy Is Fundamental to Improving Outcomes [AO Spine RECODE-DCM Research Priority Number 8].
    Davies BM; Phillips R; Clarke D; Furlan JC; Demetriades AK; Milligan J; Witiw CD; Harrop JS; Aarabi B; Kurpad SN; Guest JD; Wilson JR; Kwon BK; Vaccaro AR; Fehlings MG; Rahimi-Movaghar V; Kotter MRN
    Global Spine J; 2022 Feb; 12(1_suppl):122S-129S. PubMed ID: 35174730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Clinical Practice Guideline for the Management of Degenerative Cervical Myelopathy: Introduction, Rationale, and Scope.
    Fehlings MG; Tetreault LA; Riew KD; Middleton JW; Wang JC
    Global Spine J; 2017 Sep; 7(3 Suppl):21S-27S. PubMed ID: 29164027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS).
    Davies BM; Yanez Touzet A; Mowforth OD; Lee KS; Khan D; Furlan JC; Fehlings MG; Harrop JS; Zipser CM; Rodrigues-Pinto R; Milligan J; Sarewitz E; Curt A; Rahimi-Movaghar V; Aarabi B; Boerger TF; Tetreault L; Chen R; Guest JD; Kalsi-Ryan S; Sadler I; Widdop S; McNair AGK; Kwon BK; Kotter MRN;
    BMJ Open; 2022 Jun; 12(6):e060436. PubMed ID: 35680260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in clinical outcomes between traumatic cervical myelopathy and degenerative cervical myelopathy: A comparative study of cervical spinal cord injury without major bone injury and cervical spondylotic myelopathy.
    Machino M; Ando K; Kobayashi K; Morozumi M; Tanaka S; Ito K; Kato F; Ishiguro N; Imagama S
    J Clin Neurosci; 2019 Dec; 70():127-131. PubMed ID: 31427237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.